YG-1 Co. Ltd (019210)
KOSDAQ · Korea · prices in KRW · close of 22 Oct 2026
Key indicators
| Last close | KRW 11,070.00 |
|---|---|
| 52-week range | 4,900.00 – 28,500.00 |
| Return, 1 month / 3 months | −12.3% / −44.1% |
| Return, 1 year / 3 years | +117.9% / +127.0% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 90.8% |
| Worst drawdown (1 year) | -60.7% |
| Average daily value traded | 10,045.22M KRW |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
YG-1 Co. Ltd is a South Korean maker of cutting tools for metalworking and machining. The company produces drills, end mills, taps and other carbide and high-speed steel tooling sold under its own brand to industrial customers such as machine shops, manufacturers and distributors. Its products are used to cut, drill and shape metal parts across general engineering and production settings. YG-1 is based in South Korea and serves customers in many countries through its own sales network and distributors.
YG-1 Co. Ltd trades under the code 019210 on the KOSDAQ in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
YG-1 Co. Ltd (019210) trades on the KOSDAQ in Korea. It last closed at KRW 11,070.00 on 22 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 801 of 1,832 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 117.9% and over the last three months it fell 44.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -19.4% | ||
| From 52-week high | -58.5% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -44.1% | ||
| 6-month return | -19.6% | ||
| 12-month return, skipping the last month | 148.5% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 90.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -60.7% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 10,045.22M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.5% |
|---|---|
| 1 month | −12.3% |
| 3 months | −44.1% |
| 6 months | −19.6% |
| 1 year | +117.9% |
| 3 years | +127.0% |
| 5 years | +63.5% |
Signals
| 50-day / 200-day average | 13,630.60 / 13,729.16 |
|---|---|
| Golden / death cross (60 days) | Death, 0 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 796.49 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 190.0000 |
| 27 Dec 2024 | KRW 160.0000 |
| 27 Dec 2023 | KRW 280.0000 |
| 28 Dec 2022 | KRW 300.0000 |
| 29 Dec 2021 | KRW 180.0000 |
| 29 Dec 2020 | KRW 100.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.